Suicide is a leading cause of death among 10-to 24-year-old individuals in the United States; evidence on effective treatment for adolescents who engage in suicidal and self-harm behaviors is limited.
There are no well-established, empirically supported treatments for decreasing suicide attempts or NSSIs in adolescents with elevated suicide risk. 5, [8] [9] [10] Efforts to identify effective interventions must overcome the challenge of engaging suicidal youths in treatment because 60% to 77% of these adolescents demonstrate nonadherence with recommended care. 11 A meta-analysis 9 of 17 randomized clinical trials (RCTs) comparing defined therapeutic interventions with treatment as usual for youth with histories of self-harm (suicide attempts and NSSI combined) found a significant advantage of therapeutic interventions for reducing self-harm compared with treatment as usual. Dialectical behavioral therapy (DBT), cognitive-behavioral therapy, and mentalization-based therapy were associated with the largest effect sizes; effects were strongest for reduction in overall self-harm, whereas effects for suicide attempts were not statistically significant. Randomized clinical trials demonstrating significant effects on suicide attempts among self-harming youths are limited.
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Dialectical behavioral therapy is a multicomponent cognitive-behavioral treatment that targets treatment engagement and the reduction of self-harm and suicide attempts and focuses on teaching skills for enhancing emotion regulation, distress tolerance, and building a life worth living.
14 Research on DBT with adults has demonstrated low dropout and efficacy in reducing suicide attempts and NSSI. 15 Given its effectiveness with adults, DBT has been used for the treatment of suicidal youths with promising results. [16] [17] [18] A recent RCT with self-harming adolescents found large effect sizes for DBT in reducing self-harm and suicidal ideation relative to treatment as usual; effects were maintained at 1-year follow-up. 19, 20 Suicide attempts were, however, not examined as a separate outcome. In the present study, we focused on suicide attempts separately from overall selfharm because of the need to identify treatments that are effective for youths at the highest risk. We report primary results from a large, multisite RCT with adolescents at high risk for suicide, comparing DBT with individual and group supportive therapy (IGST) designed to match DBT for nonspecific treatment factors. This trial was powered to examine suicide attempt, NSSI, and self-harm outcomes. To strengthen power for detecting effects on suicide attempts, we selected youths at high risk for suicide attempts based on prior suicide attempts, repetitive NSSI, clinically significant suicidal ideation, and emotional dysregulation. This is the first multisite RCT, to our knowledge, that was powered to compare DBT with another manualized treatment with adolescents selected for high suicide risk and to focus on suicide attempts as the primary outcome. A priori hypotheses were that DBT would be associated with fewer suicide attempts, NSSI episodes, overall self-harm, and lower treatment dropout than IGST.
Randomization
Participants were randomized to treatment condition groups using a computerized adaptive minimization randomization procedure 24 that matched participants across conditions within sites on age, number of suicide attempts, number of previous self-injuries, and psychotropic medication use. Recruitment and assessment staff were naive to randomization status and sequence. Participants learned their treatment assignment at the first therapy session.
Treatment Conditions
The interventions were designed to offer comparable treatment exposure. Both treatments used theoretically driven treatment manuals, 6 months of weekly individual and group therapy, parent participation, and the DBT 4-miss rule, 14 which
indicates that adolescents missing 4 consecutive treatment sessions were considered to have dropped out of treatment but remained in the intention-to-treat sample and completed follow-up evaluations.
Dialectical Behavior Therapy
Dialectical behavior therapy for adolescents included 4 components: weekly individual psychotherapy, multifamily group skills training, youth and parent telephone coaching, and weekly therapist team consultation. 14, 16 Parents were seen individually in session 1 and offered 7 or more family sessions. Because adolescent DBT focuses on increasing validation in parent-teen interactions, parent participation in treatment was in family sessions. Suicide risk was monitored regularly; increased risk triggered use of the Linehan Suicide-Risk Assessment and Management Protocol.
25
Individual and Group Supportive Therapy Individual and group supportive therapy was a manualized client-centered treatment similar to comparator conditions used in prior RCTs. 26, 27 Consistent with the theory of Joiner et al 28 that emphasized "thwarted belongingness" as a suicide risk factor, IGST emphasized acceptance, validation, and feelings of connectedness and belonging. Individual and group supportive therapy included individual sessions, adolescent supportive group therapy, as-needed parent sessions (≤7 sessions), and weekly therapist team consultation. Assessment and management of suicidal behavior followed the American Academy of Child and Adolescent Psychiatry practice parameters. 29 Parent participation was in collateral sessions. Therapists were available by telephone during office hours; crisis numbers were provided for 24-hour daily coverage.
Therapist Training and Quality Assurance
Therapists provided treatment in only 1 study arm and attended a multiday training led by the treatment developer (M.M.L. for DBT and J.C. for IGST). Within each treatment group, therapists participated in weekly cross-site training and meetings and weekly site team consultation meetings (DBT) or group supervision (IGST). Treatment adherence was evaluated on randomly selected individual and group sessions once per month for therapists' first study case and once per 8 sessions for subsequent cases. Adherence ratings included detailed feedback and were reviewed weekly with remediation as needed. Adherence to DBT monitoring used the DBT Adherence Scale (computed 5-point global scale) 30 rated by the instrument's codeveloper and calibrated and reliable coders. The treatment developer (J.C.) and reliable coders rated IGST adherence using the IGST/Client Centered Therapy adherence scale. 
Assessments
Assessments occurred at baseline (before treatment), 3 months (middle of treatment), 6 months (end of treatment), 9 months, and 12 months. Assessors naive to treatment group were trained for administration and scoring of each measure. For interview measures (Suicide Attempt Self-Injury Interview [SASII] , Schedule for Affective Disorders and Schizophrenia for School-Aged Children [KSADS] , and Structured Clinical Interview for the DSM-IV, Axis II [SCID-II]) after initial training, assessors were observed, and interviews were corated by a designated criterion standard interviewer until they demonstrated 0.80 interrated reliability; thereafter, 1 in every 15 interviews was randomly selected and corated. For the KSADS and SCID-II, the measure of reliability was diagnostic agreement; for SASII, reliability was measured by item-level agreement.
Primary Outcomes
Suicide attempts, NSSI, and self-harm were measured using the SASII, which measured the frequency, intent, and medical severity of suicide attempts and NSSI episodes. 25 The SIQ-JR was used to assess suicidal ideation.
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Psychiatric Disorders and Substance Use The DSM-IV-TR diagnoses were made using the mood, anxiety, psychosis, and eating disorder modules from the KSADS. 31 Borderline personality traits were assessed using the SCID-II borderline personality disorder module. 22 The Drug Use Screening Inventory (DUSI) 32 was used to assess substance abuse. Externalizing symptoms were assessed using parent report on the Child Behavior Checklist. 33 Demographic information was assessed through parent report (youth age, sex, race/ethnicity, family income, and number of adults and children in the household).
Statistical Analysis
Treatment groups were compared on baseline demographic and clinical characteristics using χ 2 for binary and categorical variables and 2-tailed t tests for continuous variables. Logistic regression was used to identify factors related to treatment dropout and assessment nonresponse. Treatment effects were evaluated using intention-to-treat analyses. To accommodate continuous and noncontinuous outcome measures (binary, count, and ordinal), analyses were implemented using 2 mixedeffects repeated-measures techniques: mixed-model analysis of variance when change over time was nonlinear and hierarchical linear models when change followed a mathematical profile over time, such as linear, log-linear, piecewise linear, or polynomial. These analyses included treatment group (DBT, IGST) as the between-subjects factor, time (baseline and 3, 6, 9, and 12 months) as the within-subjects factor, and group × time interactions. Pairwise contrasts from the mixedeffects models were used to evaluate between-group differences. 34, 35 Outcomes analyses adjusted for site and assessed for differential treatment effects across site by including a site × treatment interaction. Site × treatment interactions were nonsignificant. Pattern-mixture models 36 assessed whether estimates in the mixed-effects models were informatively dependent on missing data patterns; analyses were not sensitive to missing data patterns. Because higher levels of treatment were predicted in DBT vs IGST, we used pattern-mixture models to evaluate evidence of an informative attrition mechanism defined in this case as differential treatment rates leading to differences in outcomes. 36, 37 We conducted secondary analyses to assess the clinical significance of between-group differences on outcomes at the posttreatment and final follow-up points, using the method of Jacobson and Truax 38 for evaluating clinical significance. Clinically significant change was defined as no self-harm during the interval. All dropouts and missing data were replaced using multiple imputation based on averaging 10 iterative Markov-Chain Monte Carlo imputations to complete the missing data, providing a full intention-to-treat analysis. To further test results, sensitivity analyses were conducted with all dropouts and missing data replaced by the previous available assessment. Proportions, odds ratios (ORs), number needed to treat, adjusted mean treatment effects, and the Cohen d for continuous variables are presented for magnitude of effects. Degrees of freedom for all mixed-effects models were estimated with the approximation of Kenward and Roger. 35 Confidence intervals were model-based derived as a function of the estimate, standard error, and respective distribution of the test statistic (ie, Wald χ 2 for ordinal mixed effects model and t distribution for the linear mixed effects model). For the SIQ-JR, we conducted a piecewise model examining change from baseline to after intervention and after intervention through follow-up. The study was designed to have a sample of 170, which is powered accounting for 20% attrition to detect a 20% difference in binary outcomes and a Cohen d = 0.35 for continuous outcomes with 86.2% power for binary outcomes and 84.1% power for continuous outcomes. 39, 40 Power calculations and all analyses were all based on 2-tailed t tests. P<.05 was considered to be statistically significant. F 2,171 = 0.81, P = .44; self-harm: F 2,171 =0. 70,P = .50; SIQ-JR: F 2,171 =1. 65,P = .19) revealed no evidence of an informative attrition mechanism on the analyses described below, indicating that results were not accounted for by differential treatment exposure.
Results

Participant Flow and Characteristics
Suicide and Self-harm: Primary Outcomes
From baseline to 6 months, 7 of 72 youths (9.7%) in the DBT group vs 14 of 65 youths (21.5%) in the IGST group reported suicide attempts. Corresponding rates reported between the 6-month and 12-month evaluations were 6 of 86 youths (7.0%) receiving DBT and 6 of 58 youths (10.3%) receiving IGST; 1 adolescent in the IGST group died by suicide in the follow-up period. The numbers of suicide attempts, NSSIs, and self-harm episodes were analyzed within a generalized linear mixed-effects model framework for ordinal data. 41 Using prespecified cut points based on prior trials, 42 frequency of suicide attempts was categorized as 0, 1, or 2 or more; NSSIs as 0, 1 through 3, 4 through 6, and 7 or more; and self-harm episodes as 0, 1 through 3, 4 through 9, and 10 or more. All tests were 2-tailed using robust SEs. Significant advantages were found for DBT on all primary outcomes after treatment (Table 3 and Figure 2 ), as indicated by the observed event rates with ORs below 1 indicating that the odds of being at a higher ordinal level are less for DBT compared with IGST. We examined the sensitivity of our ordinal mixed-effects results based on observed data categories; this analysis yielded approximate balance on the nonzero portion that consisted of any vs none for suicide attempts (OR, 0.27; 95% CI, 0.07-0.99); 0, 1, 2 through 4, 5 through 15, and 16 or more for NSSI acts (OR, 0.34; 95% CI, 0.14-0.81); and 0, 1, 2 and 3, 4 through 12, and 13 or more for self-harm acts (OR, 0.32; 95% CI, 0.14-0.75). When the ORs in Table 3 were converted to number needed to treat estimates, for the DBT group to have an additional adolescent with no suicide attempted compared with the IGST group, the number needed to treat was 8.46. Similarly, the number needed to treat estimates were 5.92 for NSSI and 5.78 for self-harm, representing a small to medium effect size range.
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Secondary analyses indicated that DBT was associated with significantly higher rates of clinically significant change, defined as the absence of any self-harm. At 6 months, in the DBT group, 40 of 86 (46.5%) showed no self-harm vs 24 of 87 (27.6%) in the IGST group; at 12 months, 44 of 86 (51.2%) in the DBT group and 28 of 87 (32.2%) in the IGST group were selfharm free. Sensitivity analyses using previous response carried forward yielded similar results.
For the SIQ-JR, the mean profile plot indicated that change during the study did not follow a linear trajectory but instead 2 phases of change. A significant advantage for DBT emerged through the end of active treatment (6 months) (t 169 =2.20, Cohen d = 0.34, P = .03) but not from end of treatment through end of follow-up (12 months) (t 169 = 0.73, Cohen d = 0.11, P = .46). The effect sizes contrast the rate and amount of change during the 2 phases on a standardized scale. After quantifying these effects on the SIQ-JR scale, compared with IGST, DBT had a mean (SE) additional reduction of 7.05 (3.21) points at 6 months, which decreased to 2.38 (3.25) points at 12 months.
Discussion
These results demonstrate the efficacy of DBT among adolescents for reducing suicide attempts, NSSI, and self-harm in a sample selected for elevated suicide risk. This is the first adolescent RCT to our knowledge to demonstrate that DBT is effective at decreasing suicide attempts. Use of manualized treatment as a control condition, designed to match DBT for nonspecific treatment components, further supports the value of DBT. Although the hypothesized posttreatment advantage for DBT occurred at 6 months, there were no statistically significant group differences at 12 months on primary outcomes because youths in both groups improved over time, providing some support for the IGST control condition. Secondary analyses of clinically significant change, as indexed by the absence of self-harm, revealed a statistically significant advantage for DBT at 12 months, with half of the youths in the DBT group reporting no self-harm vs one-third of youths in the IGST group. Although promising, these were secondary analyses; additional research should evaluate whether trials with greater statistical power or those including continuation or alternative treatment strategies might yield more sustained treatment benefits. The lack of sustained effects supports consideration of a more long-term treatment approach that views risk as continuing over time and incorporates preventive monitoring and intervention strategies. Future work is needed to address these challenges and provide families with realistic treatment expectations. Youths in the DBT group attended significantly more treatment sessions than did youths in the IGST group and were significantly more likely to complete treatment. Although results of pattern-mixture models found no evidence of an informative attrition mechanism, 44 we cannot rule out the possibility that differential treatment exposure is a mechanism that leads to the DBT outcomes. Stronger DBT treatment retention is, however, an important finding given prior research that found difficulties with treatment engagement and adherence among suicidal and self-harming youths. 10 Although parents were involved in both treatments, DBT included greater family involvement, in which parents and youths learned coping skills as opposed to IGST's nondirective approach. This difference may have contributed to both greater retention and treatment effects, particularly because stronger family components are associated with treatment benefits for adolescent self-harm.
9,12,13
Limitations
Study limitations included the predominantly female sample. Although consistent with the higher rates of suicide attempts in females and female samples in trials recruiting suicideattempting youths, 45, 46 males are more likely to die by suicide. Inclusion criteria were chosen to ensure the focus on suicidal and self-harming adolescents; future work is needed to determine whether alternative inclusion criteria (eg, multiple suicide attempts) may alter outcomes, yield more male participants, and determine whether our findings generalize to males. The 4 study sites were diverse in ethnic and racial composition, but results may not generalize more broadly. This was a highly controlled RCT with rigorous quality control and highly trained therapists; it is important to determine whether similar results emerge when treatment is delivered under more routine practice conditions.
Conclusions
This multisite RCT evaluating DBT compared with another manualized treatment demonstrated advantages of DBT for Treatment of Suicidal and Self-Injurious Adolescents with Emotional Dysregulation.
5
2) Background
7
Suicide is the third leading cause of death among adolescents in the US and yet there is a paucity of research 8 on effective treatments for this population. The primary aim of the research described in this application is to 9 evaluate the efficacy of dialectical behavior therapy (DBT) for suicidal adolescents. DBT has an empirical track record with suicidal adults of reducing the incidence, frequency and medical risk of suicide attempts and non-11 suicidal self-injuries among individuals meeting criteria for borderline personality disorder (BPD). While DBT is 12 widely used in the community with suicidal adolescents, particularly those with difficulties characteristic of BPD 13 such as poor emotion regulation and impulse control, no randomized trial of DBT with suicidal adolescents has 14 ever been conducted. And, while non-randomized trials indicate that the intervention is both safe and effective,
15
without a randomized trial we simply do not know whether DBT for suicidal adolescents is efficacious or not.
16
Given the severity of the problem and the lack of alternative treatments for high-risk adolescents, addressing 17 this question is of great importance.
19
This project is a collaborative, two site study using identical procedures and protocols at each site. Two sites,
20
Seattle and Los Angeles, are necessary in order to recruit the 170 intent-to-treat adolescent participants 
39
SPECIFIC AIMS: The overall study was designed to address multiple aims/hypothesis and exploratory
40
research questions related to both specific suicide and self-harm behaviors as well as broader functional
41
outcomes.
42
The Aims addressed in this paper are as follows:
43
AIM 1 is to evaluate the efficacy of individual and group DBT for adolescents by comparing it to a combined 
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The first aim of this research is not to demonstrate that DBT works better than usual treatment or other 72 manualized psychosocial treatments but rather to test whether DBT is itself efficacious at producing change.
73
That is, we want to interpret significant effects supporting our hypotheses as evidence that gains in the target
74
areas of the treatment are in fact due to DBT and not to non-specific factors associated with any treatment.
75
AIM 2 is to analyze mediators of reduced suicide events and NSSI in adolescents.
76
DBT is based on a theoretical model that suicidal behavior is a combined outcome of both stressful life events 77 and emotion dysregulation together with inadequate skills for solving such events or regulating negative 78 emotions. Our meditational hypotheses are based on the underlying theoretical foundation of DBT.
79
Hypo 6: Decreases in family conflict will mediate reductions in both suicide events and NSSI.
80
Hypo 7: Increases in parent DBT behavioral skills will mediate reductions in family conflict.
81
Hypo 8: Reductions in emotion dysregulation will mediate reductions in both suicide events and NSSI.
82
Hypo 9: Increases in DBT behavioral skills will mediate reductions in emotion dysregulation.
84
3) Study Design
85
This study is a randomized controlled trial of DBT compared to an active control condition (individual and group 86 supportive therapy; IGST). The study consists of an assessment component (screening/intake plus outcome 87 assessments occurring at 3 month intervals) and a treatment component (6 months).
88
Subjects will be adolescent patients and at least one of their parents/legal guardians or other responsible adult 89 authorized to participate by the parent/legal guardian. Data will be obtained by telephone and in-person, using 90 interview, questionnaire, and self-monitoring methods. Potential patient subjects and the corresponding 91 parent/other adult subject will be asked to authorize the research team (via separate written consent forms) to 92 obtain treatment records and school records which may be used to abstract data relevant to diagnosis and 93 treatment experiences, and treatment effects on school performance. All assessment and treatment sessions 94 will be video or digitally recorded for research purposes. Study therapists will also be enrolled as subjects and
95
asked for self-report data pertaining to domains such as burn-out, therapeutic alliance and treatment 96 expectancies.
97
Screening and Enrollment
98
Screening has two phases, telephone screening and in-person evaluation. (Each is described below.) To minimize 99 subject burden, individuals progress to the next screening phase only upon meeting eligibility requirements. 
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A computerized adaptive randomization procedure will be used to match patient subjects to treatment conditions 131 (DBT, IGST) within sites on five variables : 1) number of non-suicidal self-inflicted injuries in the last year(low=<6, 132 high = >6); 2) number of lifetime suicide attempts (none, >1) 3) gender; 4) age (young= <16; older = >16); and 5) 133 currently taking psychotropic medications (no, yes (including ADD/ADHD medications). Assessment personnel will 134 be kept blind to condition assignment throughout the study. Adolescent patient subjects and their parents will be 135 kept blind to treatment condition until the first treatment session.
Subjects
137
A total of 170 subjects will be enrolled in the study across sites. This is a multi-site study. 
273
of symptoms, the promotion of personal growth including enhancement of patients' strengths/coping skills and 274 capacity to use environmental supports, and to help suicidal adolescents increase their sense of self-esteem.
275
The treatment will be effective in reducing suicidal behavior and emotion dysregulation by helping the 276 adolescent patients learn to trust and validate themselves. The overarching assumption in IGST is that 277 adolescents become suicidal for a variety of reasons, but they often report feeling isolated, misunderstood, 278 unloved and unwanted. The opportunity to share their innermost concerns and feelings with an interested, 279 empathic adult may be a very beneficial experience. This model of suicidal behavior is compatible with Joiner's 280 theory that an absence of a sense of belongingness is a major risk factor for suicidal behavior.
281
IGST Interventions. There appears to be reasonable agreement in the field about the interventions in 282 supportive treatments. These interventions include providing a strong therapeutic alliance where the therapist 283 provides an environment that is completely trusting and validating. We selected IGST because it represents a 284 commonly used therapeutic approach that also includes the components included in most currently used 285 approaches to reduction of suicidal and self-injurious behaviors. It can also be readily adapted to match DBT in 286 terms of hours of treatment provided, inclusion of group and family work, and supervision structure. IGST 
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IGST Components consist of the following: 1 hr/wk individual sessions, 2 hr/wk supportive group 299 therapy, as needed telephone consultation and a 1 hr/wk therapist supervision meeting. Individual 300 sessions start with a basic orientation to supportive therapy with both the adolescent and his/her family 301 member(s). The first session also includes a discussion of the factors that contributed to the adolescent's 302 suicidal behavior, analyses of risk factors and a discussion of lethal means. All patients are asked to make a 303 no-suicide contract and procedures for risk management are discussed with both the adolescent and family.
304
Thereafter, each session starts with a mood and suicidality check and, if the patient wishes to record 305 experiences in a diary, the diary is reviewed. The session agenda is set by the patient each week. As noted 306 above, the primary target of sessions is the relief or reduction of symptoms and the promotion of personal 307 growth. As needed family and collateral therapy sessions are also scheduled as needed for psychoeducation 308 of family members, providing feedback to parents and giving time for parents to ask questions about the 309 patient's progress. The aim is to assure greater alignment of parents and teens goals for therapy. In weekly 310 supportive group therapy, group members, in consultation with the therapist, set the agenda each week. The 311 only stipulation is that each member is given some time to address his or her personal concerns. The therapist 312 both models and instructs participants in supportive interaction styles. The group focuses on the overarching 313 assumption in IGST that adolescents become suicidal for a variety of reasons, but they often report feeling 314 isolated, misunderstood, unloved and unwanted. The goal of the group, which will focus on the completion of 315 group activities (such as arts and crafts projects and reading and discussing books and movies), is to provide a community where each adolescent can feel at home and included as an insider instead of an outsider. Phone 317 calls with the therapist are used for brief crisis intervention during office hours. Families will be directed to local 318 emergency rooms, 911, psychiatric emergency response teams (e.g., the DMH Access line/PMRT) and local 319 and national suicide hotlines (e.g., 1-800-273-TALK) outside of business hours. IGST therapists and a 320 supportive therapy supervisor will meet weekly to address supervision issues relevant to provision of IGST.
321
Standard Treatment Protocols Common to DBT and IGST
322
Intensity of Treatment. Both conditions include 1 hr weekly individual sessions including as needed family 323 and collateral sessions, 2 hr group therapy, phone consultation with both adolescents and parents, and a 1 hr 324 weekly therapist consultation team meeting to enhance therapist fidelity to treatment model. In both treatment 325 conditions, the first therapy session will include a meeting with the parent(s). Thereafter, parent/collateral 326 meetings will be held on an as needed basis, with a limit of no more than 7 total sessions during the 6-month 327 treatment period (including the first session). Phone contact with parents will be unlimited and the therapist 328 may go over the 7 sessions if an emergency session with parents is needed. In DBT, the therapist may choose 329 to meet either with the parent alone or with the parent and teen together. In the IGST condition, the therapist 330 will only conduct joint meetings with parent and child to conduct crisis management (e.g., suicidality, potential 331 child abuse reporting). Given that the primary focus of IGST is the therapist/teen relationship, family sessions 332 are not typically a focus of treatment in this model (although the therapist will meet with the parent individually, 
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Patients often say they have dropped when in fact they don't mean it and even when they do mean it, they 356 often change their minds within a short period of time. This dropout rule is explained to patients and family 357 members during the first session of individual and/or group therapy and has been a standard part of DBT since 358 its inception (Linehan, 1993) .
359
Use of Psychotropic Medications During the Study. Medications/medication management will not be 360 offered as part of this study. Adolescents who enter the study on psychiatric medications can continue these 361 medications under the care of their prescribing provider. If at any time during the study the adolescent, parent 362 or therapist would like the youth to be evaluated for medication, then he/she will be referred to a community-363 based provider. This may include a provider within the study therapist's institution but medication treatment will 364 not be provided through the study. In accordance with the DBT philosophy of "consultation to the patient," in 365 the DBT condition, when possible, adolescents/parents will be coached by the therapist on how to consult with 366 the medication provider themselves regarding questions/concerns about their medication treatment. In the
367
IGST condition, the therapist and/or the adolescent/parent may consult with the medication provider as 368 needed. In both study conditions, therapists may consult directly with medication providers regarding any 369 issues directly affecting safety. A psychiatrist will be designated at each study site who will be available to hrs/7days a week should additional consultation/intervention be necessary. A modified version of the UWRAP 
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Participants will be receiving treatment as part of a research study conducted by nationally recognized 520 suicide experts. As part of the study, they will be carefully monitored by highly trained personnel and 521 receive state-of-the-art psychotherapy approaches. Hence, participation in the study is likely to lower 522 risk as compared to treatment as usual in the community. Termination of therapy may also be a cause 523 of distress. As the six-month treatment draws to an end, progress of each patient will be reviewed by 524 their individual therapist with the patient, their parent(s) and the treatment team. If additional treatment 525 is thought necessary or requested, a referral to non-study treatment in the community will be made.
526
Subjects will be informed that there is a minimal risk of loss of confidentiality. All study personnel will be 527 trained in the research ethics and protocols for maximizing integrity and confidentiality of clinical 528 information and research data. Further, we have obtained a NIH Certificate of Confidentiality to help 529 protect against outside attempts to gain access to research data.
A Data Safety Monitoring Board (DSMB) will be created to monitor the safety of participants throughout 532 the trial. The DSMB will monitor the execution of the research protocol and study procedures and will 533 ensure that reporting of adverse events follows the requirements of the respective institutions and NIH.
534
The DSMB will meet to review the protocol and procedures at study start, including review of how 535 adverse events will be defined in the course of the trial and the reporting procedures. The DSMB will 536 conduct regular reviews thereafter to determine whether patient safety is being adequately safeguarded 537 and study goals are being met. At each review, the DSMB will examine whether the emerging pattern of 538 findings alters the risk-benefit ratio to the point that the study needs to be discontinued. The DSMB will 539 be kept apprised of adverse and notable events on an ongoing basis and serve as the final arbiter of 540 whether individual patients should be removed from the protocol. During the course of treatment, the 541 adolescent/family, the therapist or the study PIs may question the appropriateness of a particular 542 patient continuing in the study or whether the treatment should be modified. With some adolescents, it 543 may become clinically necessary to arrange for ancillary services such as a case manager or brief 544 inpatient admission. If the youth is determined to be a possible danger to self or others, he/she will be 545 referred for emergency evaluation and possible hospitalization. In such cases an outside clinical expert 546 consultant to be designated at each site may be called in to evaluate the adolescent for purposes of 547 determining whether the treatment being provided is related to the deterioration in the adolescent's 548 psychiatric status and whether the adolescent's treatment should be changed in any way. Should the 549 consultant believe that the patient is being harmed by the treatment or research protocol, the consultant 550 will discuss possible termination from the study. All subjects who wish to receive additional treatment at 551 the conclusion of their participation (regardless of whether they dropped from treatment, completed 552 treatment, or were terminated at consultant recommendation) will receive appropriate referrals. It is 553 possible that youths will be enrolled in the study but that information obtained after enrollment will raise 554 questions regarding inclusion/exclusion criteria (e.g. evidence of psychotic symptoms might emerge). In 555 these instances, we will assist in linking the youth to appropriate treatment and withdraw them from the 556 study.
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The DSMB will be chaired by Dr. Donald Guthrie. Dr. Guthrie has previously consultant to the 559 investigators at the UW site and has served as DSMB chair for several studies with the UCLA 560 investigators. The remainder of the board will (minimally) consist of one psychiatrist with expertise in 561 treating highly suicidal and depressed adolescents, one mental health specialist (MSW, PhD, PsyD or 562 MD) in the area of suicidal and life-threatening behaviors, one mental health specialist (MSW, PhD,
563
PsyD or MD) in the area of child/adolescent mental health, and one biostatistician. The primary role of 564 the Data Safety Monitoring Board (DSMB) is to monitor the safety of participants throughout the trial at 565 the respective sites. The DSMB will monitor the execution of the research protocol and study 566 procedures and will ensure that reporting of adverse events follows the requirements of the respective 567 institutions and NIH.
568
Any patient who commits suicide during the course of the study will be reported immediately (i.e., within 
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There are three primary outcome domains: suicidal attempts, non-suicidal self-injury and suicidal 622 ideation. Treatment maintenance and functional improvement is also assessed. Suicidal events will be 623 defined as either a suicide, suicide attempt (defined as self-injurious behavior with some non-zero 624 intent to die as a result of this behavior) and suicidal ideation. We will also examine the number of non-625 suicidal self-injury behaviors. The primary measure of treatment maintenance will be days in treatment.
627 Statistical Analyses
628
As stated above, our hypotheses are as follows:
629
Hypo 1: Suicide events (suicide, suicide attempt, suicidal ideation) will be less likely in DBT vs. IGST 630 during the treatment and follow-up period.
631
Hypo 2: NSSI will be less likely in DBT vs. IGST during the treatment and follow-up period.
632
Hypo 3: Days in treatment will be higher and treatment dropout will be lower in DBT vs. IGST.
633
In the presence of a large proportion of data stacked at one response such as zero, which may occur, 
